<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02154516</url>
  </required_header>
  <id_info>
    <org_study_id>2011-ODHH166</org_study_id>
    <nct_id>NCT02154516</nct_id>
  </id_info>
  <brief_title>Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System</brief_title>
  <official_title>A Consecutive Series Pilot Study Evaluating the Safety and Effectiveness of a New Hard-on-Hard Total Hip Replacement System in Patients With Non-inflammatory Arthritis With a Standard THA Metal Ion Control Group</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew, Inc.</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the early and long term safety and efficacy of the
      hard-on-hard total hip replacement system (R3 ODH-ODH utilization) in patients with
      non-inflammatory arthritis.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 4, 2011</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Revision Rate</measure>
    <time_frame>Up to 10 Years</time_frame>
    <description>Reoperations that led to removal or replacement of any of the acetabular or femoral components.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Up to 10 Years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Metal Ion Concentration in Whole Blood</measure>
    <time_frame>Up to 10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Harris Hip score</measure>
    <time_frame>Up to 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hip Disability and Osteoarthritis Outcome Scores (HOOS)</measure>
    <time_frame>Up to 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic measures</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Assessment of bone loss, radiolucencies, subsidence, and heterotopic ossification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economic outcomes-Surgical blood loss</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Measured in ml blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economic outcomes -Length of hospital stay</measure>
    <time_frame>Hospital admission to discharge</time_frame>
    <description>Measure of days spent in hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economic outcomes-Operative time</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Operative time - first incision into skin to time when last suture is applied</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economic outcomes - Re-hospitalisations</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Re-hospitalisations-number of re-admissions to hospital</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Arthritis, Degenerative</condition>
  <arm_group>
    <arm_group_label>Control Total Hip Replacement Device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Total Hip replacement surgery using control device consisting of a hard-on-soft bearing or a ceramic-on-ceramic bearing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Investigational Hard-on-Hard Total Hip Replacement Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Total Hip replacement surgery using an experimental device consisting of a hard-on-hard bearing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ODH Hip System</intervention_name>
    <arm_group_label>Control Total Hip Replacement Device</arm_group_label>
    <arm_group_label>Investigational Hard-on-Hard Total Hip Replacement Device</arm_group_label>
    <other_name>Total Hip Replacement</other_name>
    <other_name>THR</other_name>
    <other_name>Total Hip Arthroplasty</other_name>
    <other_name>THA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 21 years old

          -  Skeletally mature

          -  Requires primary, unilateral total hip arthroplasty due to degenerative join disease

          -  Preoperative Harris Hip Score of less than or equal to 70

          -  Meets an acceptable preoperative medical clearance and is free or treated for
             conditions that would pose excessive operative risk

          -  Given consent to participate in the study

          -  Able to understand the purpose of the study, his/her role, and is available for
             follow-up

             10 year extension:

               -  Subject has completed the 2 year primary study

               -  Subject has signed an Independent Ethics Committee (IEC) approved Informed
                  Consent Form agreeing to participate in the extension study after the nature,
                  scope and possible consequences of the study have been explained in an
                  understandable form

               -  Subject is able to fully understand the purpose of the study, his/her role as a
                  participant in the study, and plans to be available through ten years
                  post-operative follow-up

        Exclusion Criteria:

          -  Diagnosis with high risk of Total Hip Arthroplasty (THA) failure

          -  Requires bilateral THA

          -  Requires revision of a prior hip replacement

          -  Active infection or sepsis

          -  History of local hip infection

          -  Known metastatic or neoplastic disease

          -  Conditions that may interfere with THA survival or outcomes

          -  Need for structural bone grafts to support the implant

          -  Contralateral lower extremity condition

          -  Has other joint replacements or plans for other joint replacements within 2 years

          -  Systemic steroid therapy within 3 months prior to surgery

          -  Life expectancy less than 2 years

          -  Intra-articular therapy within 6 months of enrollment

          -  Female of child-bearing age not using contraception

          -  Inadequate bone stock to support the device

          -  Moderate to severe renal insufficiency

          -  Emotional or neurological condition that would pre-empt ability or willingness to
             participate in the study

          -  BMI &gt;40

          -  Above the knee amputation of the contralateral or ipsilateral leg

          -  Known allergies to the components of the devices

          -  Entered into another investigational study

          -  Is a prisoner

             10 year extension:

             â€¢ In the opinion of the surgeon, the subject's health, safety or well-being may be
             compromised or harmed by continuation in the extension phase or participation may not
             be in the subject's best interests.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Baker</last_name>
    <role>Principal Investigator</role>
    <affiliation>Entabeni Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johannes de Beer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zuid Afrikaans Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Entabeni Hospital</name>
      <address>
        <city>Durban</city>
        <zip>4001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zuid Afrikaans Hospital</name>
      <address>
        <city>Pretoria</city>
        <zip>0002</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>South Africa</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2014</study_first_submitted>
  <study_first_submitted_qc>May 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

